4
Changes in Ownership
Arcus Biosciences, Inc. Filed Acc 0001771961-25-000014
Chief Accounting Officer sold 8,832 shares at an average $22.13 ($195,434)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Azoy Alexander · Chief Accounting Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-16 | Sale : show line 1 in the form 10b5-1 | −2,376 | $21.88 | $51,997 | 24,987 | D |
| 2025-12-17 | Sale : show line 2 in the form 10b5-1 | −2,113 | $22.16 | $46,823 | 22,874 | D |
| 2025-12-18 | Sale : show line 3 in the form 10b5-1 | −4,343 | $22.25 | $96,614 | 18,531 | D |
| Open-market sales · 8,832 sh · avg $22.13 · $195,434 | ||||||
Loading xslF345X05/wk-form4_1766097326.xml…